# US 2025/0143622 A1 · System and method for monitoring and managing a cardiac health status

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0143622 A1
- Document ID: US20250143622A1
- Status: Published application
- Kind: A1
- Application number: 18/726,321
- Filed: 2023-01-04
- Published: 2025-05-08
- Earliest claimed: 2022-01-05
- Assignees: Prolaio, Inc.
- Applicants: Prolaio, Inc.
- Inventors: Jay M. Edelberg; Tassos Gianakakos
- Web page: https://patentgrep.com/patent/US20250143622A1

## CPC

- A61B 5/0035: {adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography}
- A61B 5/7267: {involving training the classification device}
- A61B 5/02007: {Evaluating blood vessel condition, e.g. elasticity, compliance}
- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/026: Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)}
- A61B 5/029: Measuring blood output from the heart, e.g. minute volume
- A61B 5/1073: {Measuring volume, e.g. of limbs}
- A61B 5/1075: {for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer (A61B8/0858 takes precedence)}
- A61B 5/1076: {for measuring dimensions inside body cavities, e.g. using catheters (A61B3/1005 takes precedence)}
- A61B 5/1107: {Measuring contraction of parts of the body, e.g. organ or muscle}
- A61B 5/1118: {Determining activity level}
- A61B 5/256: Wearable electrodes, e.g. having straps or bands
- A61B 5/282: Holders for multiple electrodes (for introduction into the body A61B5/287)
- A61B 5/332: Portable devices specially adapted therefor
- A61B 5/339: Displays specially adapted therefor
- A61B 5/346: Analysis of electrocardiograms
- A61B 5/353: Detecting P-waves
- A61B 5/355: Detecting T-waves
- A61B 5/358: Detecting ST segments
- A61B 5/361: Detecting fibrillation
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61B 5/4806: {Sleep evaluation (A61B5/4821 takes precedence; devices for inducing sleep A61M21/02)}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/743: {Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots}
- A61B 5/7435: {Displaying user selection data, e.g. icons in a graphical user interface}
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- A61B 8/02: Measuring pulse or heart rate
- A61B 8/04: Measuring blood pressure
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- A61B 5/0044: {for the heart}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 8/0883: {for diagnosis of the heart}
- A61B 2576/023: for the heart
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Disclosed herein, in some aspects, are systems and methods for monitoring a cardiac health status for a subject. In some embodiments, the systems and methods comprise: a) obtaining a first set of subject health parameters of the subject; b) determining a baseline cardiac health status; c) obtaining a set of ambulatory monitoring parameters of the subject; d) determining a subsequent cardiac health status by applying a second set of decision engines with one or more ambulatory monitoring parameters; and e) identifying a change from the baseline cardiac health status to the subsequent cardiac health status.

## Claims

### Claim 1

A method for monitoring a cardiac health status for a subject, the method comprising:
a. obtaining a first set of subject health parameters of the subject, wherein the first set of subject health parameters comprises i) electrocardiogram (ECG) data, ii) clinical biomarker data, iii) imaging data, and/or iv) clinical parameters;
b. determining a baseline cardiac health status by applying a first set of decision engines with one or more subject health parameters of the first set of subject health parameters to determine i) an initial cardiac condition in the subject, and/or ii) an initial risk score for developing the initial cardiac condition by the subject;
c. obtaining a set of ambulatory monitoring parameters of the subject, wherein the set of ambulatory monitoring parameters is obtained temporally subsequent to obtaining the first set of subject health parameters;
d. determining a subsequent cardiac health status by applying a second set of decision engines with one or more ambulatory monitoring parameters of the set of ambulatory monitoring parameters to determine i) a change in severity of the initial cardiac condition, ii) a change in the initial risk score, iii) a subsequent cardiac condition in the subject, and/or iv) a subsequent risk score for developing the subsequent cardiac condition by the subject; and
e. identifying a change from the baseline cardiac health status to the subsequent cardiac health status.

### Claim 2 (depends on 1)

The method of claim 1, further comprising outputting an alert based on the identified change, wherein the change comprises i) an increase in the severity of the initial cardiac condition, ii) an increase in the initial risk score, iii) the subsequent cardiac condition in the subject, and/or iv) the subsequent risk score.

### Claim 3 (depends on 1)

The method of claim 1, further comprising repeating steps (c) to (e) a plurality of times for a prescribed duration, thereby providing monitoring of the cardiac health status of the subject for the prescribed duration.

### Claim 4 (depends on 3)

The method of claim 3, wherein the set of ambulatory monitoring parameters are obtained according to a temporal frequency during the prescribed duration.

### Claim 5 (depends on 4)

The method of claim 4, wherein the temporal frequency is every hour, every 6 hours, every 12 hours, daily, every other day, weekly, bi-weekly, monthly, or bi-monthly.

### Claim 6 (depends on 1)

The method of claim 1, wherein the set of ambulatory monitoring parameters is obtained temporally subsequent to determining the baseline cardiac health status.

### Claim 7 (depends on 1)

The method of claim 1, wherein the set of ambulatory monitoring parameters comprises electrocardiogram (ECG) data and/or one or more clinical parameters.

### Claim 8 (depends on 7)

The method of claim 7, wherein the one or more clinical parameters comprises the subject's age, sex, weight, body mass index, height, physiological data, exercise testing results, heart rate, activity levels, velocity, sleep data, or a combination thereof.

### Claim 9 (depends on 7)

The method of claim 7, wherein the ECG data is obtained via ECG device, wherein the ECG device comprises a 12-lead device, a 6-lead device, a 1-lead device, or a 2-lead device.

### Claim 10 (depends on 9)

The method of claim 9, wherein the ECG device comprises a wearable device.

### Claim 11 (depends on 1)

The method of claim 1, wherein one or more subject health factors of the first set of subject health factors correspond to ECG data and/or one or more clinical parameters of the clinical parameters, wherein said ECG data and one or more clinical parameters are obtained via ambulatory measurement.

### Claim 12 (depends on 1)

The method of claim 1, wherein the clinical biomarker data comprise data for one or more of B-type natriuretic peptide (BNP), N-terminal(NT)-pro hormone BNP (NT-proBNP), and cardiac troponin.

### Claim 13 (depends on 1)

The method of claim 1, wherein the imaging data comprises one or both of an echocardiogram image and a cardiac MRI.

### Claim 14 (depends on 1)

The method of claim 1, wherein one or both of the first cardiac condition and the subsequent cardiac condition comprise a cardiac disease.

### Claim 15 (depends on 1)

The method of claim 1, wherein the first cardiac condition comprises cardiomyopathy, hypertrophic cardiomyopathy, pulmonary arterial hypertension, amyloid cardiomyopathy, reduced ejection fraction heart failure, arrhythmia (which can include atrial fibrillation), heart failure, heart attack, stroke, myocardial ischemia (including macrovascular and/or microvascular), left atrial myopathy, left atrial enlargement (LAE), diastolic dysfunction, or any combination thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein the subsequent cardiac condition comprises cardiomyopathy, hypertrophic cardiomyopathy, pulmonary arterial hypertension, amyloid cardiomyopathy, reduced ejection fraction heart failure, arrhythmia (which can include atrial fibrillation), heart failure, heart attack, stroke, myocardial ischemia (including macrovascular and/or microvascular), left atrial myopathy, diastolic dysfunction, or any combination thereof.

### Claim 17 (depends on 1)

The method of claim 1, wherein one or both of the first set of decision engines and the second set of decision engines comprise a trained model, a decision tree, an analytical expression, or a combination thereof.

### Claim 18 (depends on 1)

The method of claim 1, wherein the first set of decision engines and the second set of decision engines each comprise one or more decision engines.

### Claim 19 (depends on 18)

The method of claim 18, wherein at least one decision engine is found in both the first set of decision engines and the second set of decision engines.

### Claim at position 20

20-38. (canceled)

### Claim 39

A system for monitoring a cardiac health status for a subject, the system comprising:
one or more processors; and
one or more memories storing instructions that, when executed by the one or more processors, cause the system to perform operations including:
a. obtaining a first set of subject health parameters of the subject, wherein the first set of subject health parameters comprises i) electrocardiogram (ECG) data, ii) clinical biomarker data, iii) imaging data, and/or iv) clinical parameters;
b. determining a baseline cardiac health status by applying a first set of decision engines with one or more subject health parameters of the first set of subject health parameters to determine i) an initial cardiac condition in the subject, and/or ii) an initial risk score for developing the initial cardiac condition by the subject;
c. obtaining a set of ambulatory monitoring parameters of the subject, wherein the set of ambulatory monitoring parameters is obtained temporally subsequent to obtaining the first set of subject health parameters;
d. determining a subsequent cardiac health status by applying a second set of decision engines with one or more ambulatory monitoring parameters of the set of ambulatory monitoring parameters to determine i) a change in severity of the initial cardiac condition, ii) a change in the initial risk score, iii) a subsequent cardiac condition in the subject, and/or iv) a subsequent risk score for developing the subsequent cardiac condition by the subject; and
e. identifying a change from the baseline cardiac health status to the subsequent cardiac health status.

### Claim 40 (depends on 39)

The system of claim 39, wherein the operations further include outputting an alert based on the identified change, wherein the change comprises i) an increase in the severity of the initial cardiac condition, ii) an increase in the initial risk score, iii) the subsequent cardiac condition in the subject, and/or iv) the subsequent risk score.

### Claim 41 (depends on 39)

The system of claim 39, wherein the operations further include repeating steps (c) to (e) a plurality of times for a prescribed duration, thereby providing monitoring of the cardiac health status of the subject for the prescribed duration.

### Claim at position 24

42-43. (canceled)

### Claim 44 (depends on 39)

The system of claim 39, wherein the set of ambulatory monitoring parameters is obtained temporally subsequent to determining the baseline cardiac health status.

### Claim 45 (depends on 39)

The system of claim 39, wherein the set of ambulatory monitoring parameters comprises electrocardiogram (ECG) data and/or one or more clinical parameters.

### Claim at position 27

46-48. (canceled)

### Claim 49 (depends on 39)

The system of claim 39, wherein one or more subject health factors of the first set of subject health factors correspond to ECG data and/or one or more clinical parameters of the clinical parameters, wherein said ECG data and one or more clinical parameters are obtained via ambulatory measurement.

### Claim 50 (depends on 39)

The system of claim 39, wherein the clinical biomarker data comprise data for one or more of B-type natriuretic peptide (BNP), N-terminal(NT)-pro hormone BNP (NT-proBNP), and cardiac troponin.

### Claim 51

(canceled)

### Claim 52 (depends on 39)

The system of claim 39, wherein one or both of the first cardiac condition and the subsequent cardiac condition comprise a cardiac disease.

### Claim at position 32

53-54. (canceled)

### Claim 55 (depends on 39)

The system of claim 39, wherein one or both of the first set of decision engines and the second set of decision engines comprise a trained model, a decision tree, an analytical expression, or a combination thereof.

### Claim 56 (depends on 39)

The system of claim 39, wherein the first set of decision engines and the second set of decision engines each comprise one or more decision engines.

### Claim 57 (depends on 56)

The system of claim 56, wherein at least one decision engine is found in both the first set of decision engines and the second set of decision engines.
